---
schema_version: "secwatch.filing_event.v1"
accession: "0001606757-26-000012"
form_type: "8-K"
ticker: "KE"
cik: "0001606757"
company_name: "Kimball Electronics, Inc."
filed_at: "2026-05-05T23:59:59+00:00"
generated_at: "2026-05-14T23:23:24.813395+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Kimball Electronics Q3 revenue $352.9M, medical sales up 10.2% sequentially, affirms FY2026 guidance

## Summary
- Revenue $352.9M, up 3.4% sequentially; medical vertical sales grew 10.2% vs Q2.
- Operating income $11.8M (3.3% of sales); adjusted operating margin 4.2%.
- Cash from operations $14.9M, positive for 9th consecutive quarter; debt $163.0M, borrowing capacity $276.0M.
- Cash conversion days improved to 90; repurchased 165,000 shares for $4.0M.
- Affirms FY2026 guidance: net sales $1.4-1.46B; adjusted op margin 4.2-4.5% expected at high end; capex $50-60M.

## SEC filing metadata
- accession: 0001606757-26-000012
- form_type: 8-K
- ticker: KE
- cik: 0001606757
- company_name: Kimball Electronics, Inc.
- filed_at: 2026-05-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606757/000160675726000012/0001606757-26-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606757/000160675726000012/ke-20260505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606757-26-000012
- JSON: https://secwatch.observer/filing/0001606757-26-000012.json
- Plain text: https://secwatch.observer/filing/0001606757-26-000012.txt

## Source-grounded claims
- claim_id: 4b9436307ae36ce88cb8e2434d392be9bafba884
  claim: Kimball Electronics, Inc. reported third quarter ended March 31, 2026 results: revenue $352.9 million. Guidance reaffirmed.
  evidence_excerpt: strategy. We believe this could be a powerful combination for the future of our Company.” Richard D. Phillips Chief Executive Officer Third Quarter 2026 Highlights • Revenue of $352.9 million, a sequential increase of 3.4% compared to Q2 • Sales in the medical vertical increased 10.2% versus the prior quarter • Operating income of $11.8 million, or 3.3% of net sales,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606757/000160675726000012/0001606757-26-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.